What is DCA Pharmacy?
DCA Pharmacy operates as a premier full-service pharmacy, distinguishing itself through high-precision custom compounding solutions. The firm provides a diverse portfolio of therapeutic products, including bio-identical hormone replacement therapy, specialized pain management topicals, and proprietary formulations such as Synapsin Nasal Spray. By maintaining a rigorous commitment to quality control and regulatory compliance, the company serves a broad patient base across 48 states. Their integrated business model, which features a secure digital ordering platform, facilitates seamless medication management and reliable fulfillment, positioning DCA Pharmacy as a critical player in the personalized healthcare ecosystem.
How much funding has DCA Pharmacy raised?
DCA Pharmacy has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in DCA Pharmacy
PPP
Public-Private Partnership
What's next for DCA Pharmacy?
With the successful closure of this late-stage financing, DCA Pharmacy is poised to scale its infrastructure to meet the rising demand for personalized pharmaceutical care. The strategic allocation of this capital will likely focus on enhancing production capacity, optimizing supply chain logistics, and potentially expanding its proprietary product pipeline. As the healthcare industry continues to shift toward patient-centric, customized treatment plans, DCA Pharmacy is strategically aligned to capture additional market share. The firm's ability to maintain high standards of precision while scaling operations across a national footprint remains a key indicator of its long-term growth potential and operational resilience in a competitive landscape.
See full DCA Pharmacy company page
